Mercier Johanna (CIK 1782135) reported 58 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-16). Recent activity: Sell GILD (1,480 shares), Sell GILD (1,070 shares), Sell GILD (450 shares), Buy GILD (2,796 shares), Sell GILD (1,341 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 1,480 | $182,657 |
| 2026-06-16 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 1,070 | $132,676 |
| 2026-06-16 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 450 | $56,430 |
| 2026-06-11 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Buy | 2,796 | $0 |
| 2026-06-11 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 1,341 | $162,905 |
| 2026-05-21 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 3,318 | $0 |
| 2026-05-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Buy | 25,000 | $1.7M |
| 2026-05-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 7,749 | $1.0M |
| 2026-05-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 11,177 | $1.5M |
| 2026-05-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 8,374 | $1.1M |
| 2026-05-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 700 | $92,926 |
| 2026-04-16 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 3,000 | $422,880 |
| 2026-03-17 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 3,000 | $432,690 |
| 2026-03-12 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Buy | 6,617 | $0 |
| 2026-03-12 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 3,216 | $477,769 |
| 2026-03-02 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Buy | 11,090 | $0 |
| 2026-02-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Buy | 25,000 | $1.7M |
| 2026-02-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 18,405 | $2.8M |
| 2026-02-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 9,395 | $1.5M |
| 2026-02-18 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 200 | $31,124 |
| 2026-02-05 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Buy | 44,867 | $0 |
| 2026-02-05 | GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | Sell | 24,800 | $3.6M |
| 2026-01-16 | GILEAD SCIENCES, INC. (GILD) | Chief Commercial Officer | Sell | 3,000 | $372,930 |
| 2025-12-16 | GILEAD SCIENCES, INC. (GILD) | Chief Commercial Officer | Sell | 3,000 | $366,000 |
| 2025-12-11 | GILEAD SCIENCES, INC. (GILD) | Chief Commercial Officer | Buy | 3,842 | $0 |
Source: SEC Form 4 filings · as of 2026-06-16